TelevisitMD Owner Christopher Harwood Sentenced to 20 Years in $46 Million Medicare Fraud

A South Florida businessman who ran a telemedicine company at the center of a long-running Medicare fraud conspiracy has been sentenced to 20 years in federal prison, one of the stiffest terms handed down in a telehealth-linked fraud case. Christopher Harwood, the owner of Fort Lauderdale-based TelevisitMD, pleaded guilty earlier in 2026 to organizing a scheme that billed Medicare for orthotic braces and genetic tests that patients did not need.

The case is a textbook example of how fraud operators use the language and infrastructure of telemedicine as cover. The doctors involved were not practicing legitimate telehealth. Prosecutors said they signed orders for patients they never meaningfully evaluated, in exchange for money that flowed through Harwood's companies.

What the Justice Department announced

The Justice Department said Harwood was sentenced to 20 years in prison for his role in a Medicare fraud conspiracy that spanned more than six years. News of the sentence was reported on October 23, 2026. Beyond the prison term, the reported sentence orders Harwood to pay $17,942,402 in restitution to Medicare and to forfeit $10,431,463 in proceeds traceable to the fraud.

Harwood pleaded guilty in March 2026 to conspiracy to commit health care fraud and conspiracy to commit wire fraud. When he entered that plea, the Justice Department described him as having organized and led the conspiracy, and he agreed at the time to pay restitution equal to the amount Medicare had paid out. The case was filed in the U.S. District Court for the Southern District of Florida.

How the TelevisitMD scheme worked

According to the Justice Department, the fraud followed a pattern federal investigators have seen repeatedly in durable medical equipment (DME) and genetic-testing cases:

• Telemarketing operations contacted Medicare beneficiaries and persuaded them to accept orthotic braces and genetic tests they did not need.
• Harwood paid doctors to approve the resulting orders. Prosecutors said those doctors did not follow Medicare's telemedicine rules and had no real medical relationship with the patients, often signing off without any meaningful interaction.
• Harwood then sold the signed doctors' orders to DME suppliers, laboratories, and other marketers, who used them to bill Medicare.
• At least $46.2 million in false and fraudulent claims reached Medicare as a result, and Medicare paid roughly $17.9 million on them.

Of the money Medicare paid, Harwood personally received more than $10.4 million, prosecutors said. The signed order was the product being sold: a piece of paper that let a supplier or lab turn a cold telemarketing call into a reimbursable Medicare claim.

Why the telemedicine rules matter here

Medicare pays for telehealth only when a real clinical encounter takes place and the ordering provider has a legitimate relationship with the patient. In this case, prosecutors said that relationship did not exist. The doctors functioned as signature machines, approving orders generated by marketing rather than by patient need.

That distinction is the whole case. Legitimate telehealth connects a patient to a licensed clinician who evaluates them and documents a medical reason for what is ordered. A sham telemedicine operation borrows the format, the video visit, the electronic order, the remote provider, while stripping out the clinical substance that makes the order valid. The Harwood sentence underscores that prosecutors treat the paperwork trail of a telehealth visit as evidence, not as a shield.

Part of a wider enforcement push

The TelevisitMD case was investigated by the Department of Health and Human Services Office of Inspector General (HHS-OIG) and the FBI and prosecuted through the Justice Department's Health Care Fraud Strike Force, which targets exactly this model of telemarketing, paid orders, and DME or lab billing.

It lands amid a run of similar sentences. Earlier in October 2026, federal prosecutors announced a 19-year sentence for the operator of the DMERx platform in a scheme prosecutors valued at more than $1 billion, and a Massachusetts physician was sentenced over telemedicine kickbacks tied to DME and genetic testing. The common thread is not the technology but the incentive structure: pay a clinician for a signature, and the order becomes a billable claim no matter whether the patient needed the item.

What this means for patients and the telehealth industry

For patients, the practical risk is receiving a brace or a genetic test kit that was ordered by a doctor they never really saw, with the cost billed to Medicare in their name. Unneeded items waste benefits, can trigger confusing bills, and expose a beneficiary's Medicare number to further misuse.

For the broader telehealth industry, the message from the bench is that long prison terms are now on the table for fraud dressed up as telemedicine. Compliant virtual-care companies are not the target of these prosecutions, but the cases keep telehealth ordering under scrutiny, which is one reason regulators continue to tighten documentation standards for remote visits and remote orders.

How to report suspected Medicare fraud

This is general information, not legal or medical advice. If you think you have been billed for equipment or tests you did not need or did not receive, a few steps are reasonable:

• Review your Medicare Summary Notice or your online Medicare account for braces, tests, or telehealth visits you do not recognize.
• Report suspected fraud to the HHS Office of Inspector General hotline at 1-800-HHS-TIPS (1-800-447-8477) or through tips.hhs.gov, and to Medicare at 1-800-MEDICARE.
• Guard your Medicare number the way you would a credit card, and be wary of unsolicited calls or ads offering free braces, genetic tests, or other items in exchange for your Medicare information.
• Talk with your own licensed clinician about whether a test or device is appropriate before accepting one that a stranger offered you.